|1.||Takeda, Shuichi: 5 articles (01/2008 - 02/2004)|
|2.||Ono, Takahiko: 3 articles (01/2011 - 09/2004)|
|3.||Hattori, Tomohisa: 3 articles (01/2008 - 03/2006)|
|4.||Kase, Yoshio: 3 articles (01/2008 - 03/2006)|
|5.||Kadowaki, Makoto: 2 articles (01/2015 - 01/2010)|
|6.||Hayasaka, Seiji: 2 articles (01/2012 - 01/2002)|
|7.||Nogaki, Fumiaki: 2 articles (01/2011 - 01/2005)|
|8.||Shimizu, Masahiko: 2 articles (01/2010 - 01/2010)|
|9.||Kano, Takashi: 2 articles (01/2010 - 01/2010)|
|10.||Kanda, Takayoshi: 2 articles (01/2010 - 01/2010)|
|1.||Nephrotic Syndrome (Syndrome, Nephrotic)
01/01/1990 - "Although we could consider Sairei-To effective for steroid-dependent nephrotic syndrome in the present study, a larger study is necessary to confirm its efficacy."
01/01/1995 - "37 children with steroid-dependent nephrotic syndrome (SDNS) were administered with Chai-Ling-Tang (Sairei-to) under corticosteroid. "
01/01/1995 - "Therapeutic effect of chai-ling-tang (sairei-to) on the steroid-dependent nephrotic syndrome in children."
01/01/1990 - "Sairei-To (Chai-Ling-Tang) was administered to four patients with steroid-dependent relapsing nephrotic syndrome. "
01/01/1990 - "Effects of sairei-to on the relapse of steroid-dependent nephrotic syndrome."
12/01/1991 - "Proteinuria and serum triglyceride levels were significantly reduced in the sairei-to-treated groups showed a morphological improvement in the kidney over the PAN group. "
03/01/2007 - "(GTW) and Sairei-to on mesangial damage and proteinuria, and then to clarify the mechanism of these herbs at molecular level by examining the effects on various injurious factors."
07/01/1997 - "The level of proteinuria in the Sairei-to-treated group was significantly lower than that in the PBS treated group. "
03/01/1997 - "TJ-114 prevented proteinuria and histopathological changes in the glomeruli of nephritic rats. "
05/01/1994 - "The effect of Sairei-to on a non-immunological model of proteinuria was also examined. "
01/01/2005 - "Our previous studies have demonstrated that Sairei-to can significantly prevent progression of experimental glomerulonephritis in rats. "
01/01/2005 - "Suppressive mechanisms of Sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis."
09/01/2004 - "Suppressive effects of Sairei-to on mesangial proliferation in a rat model of glomerulonephritis."
07/01/1997 - "Suppressive effects of sairei-to on monoclonal antibody 1-22-3-induced glomerulonephritis: analysis of effective components."
07/01/1997 - "The effects of traditional Chinese medicine (Sairei-to) on experimental glomerulonephritis induced in rats by monoclonal antibody (mAb) 1-22-3 injection was examined. "
01/01/2011 - "These results suggest that sairei-to ameliorates peritoneal fibrosis, partly through suppressing oxidative stress and macrophage infiltration."
01/01/2011 - "Sairei-to ameliorates rat peritoneal fibrosis partly through suppression of oxidative stress."
01/01/2011 - "We conducted an experimental study on rat peritoneal fibrosis to clarify the suppressive mechanisms of sairei-to. "
01/01/2015 - "Daily administration of saireito reduced the severity of intestinal mucositis in a dose-dependent manner. "
01/01/2015 - "In the present study, we investigated the effect of saireito on 5-FU-induced intestinal mucositis in mice, especially in relation to apoptosis in the intestinal crypt. "
01/01/2015 - "These results suggest that saireito attenuates 5-FU-induced intestinal mucositis. "
01/01/2015 - "Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells."
01/01/2015 - "Therefore, saireito may be clinically useful for the prevention of intestinal mucositis during cancer chemotherapy. "
|7.||Idiopathic minimal change nephrotic syndrome
|1.||Kampo Medicine (Kampo)
|4.||Chinese Traditional Medicine (Traditional Chinese Medicine)